Emerging Priorities and Consumer Driven Research Initiative

Grant Objectives:

Link researchers, institutions, policy makers and professional associations to gather evidence on the physiological and mental health effects of bushfires and exposure to hazardous smoke over time.

Traumatic Brain Injury Mission

Grant Objectives:

Support clinical research that improves knowledge and its translation into practice in order to enhance personalisation of care after traumatic brain injury (TBI).

The expected outcome of the research is innovative diagnostic and prognostic methods that facilitate longer term advances in TBI treatment and drive improvements in health and social outcomes for patients after TBI and people around them.

Stem Cell Therapies Mission

Grant Objectives:

To prime teams working on ‘proof of concept’ stem cell research targeted towards a health care outcome. Funding for such priming programs will target two priority areas aimed at driving innovation and accelerating implementation into clinical practice:

1. Stem cell therapies
2. New treatments using human tissues made from stem cells.

Cardiovascular Health Mission

Grant Objectives:

• Improving prevention of heart disease and stroke
• Improved survival outcomes after an acute heart or stroke event through a focus on treatment
• Improving secondary prevention and survivorship after a cardiovascular event.

Global Health Initiative

Grant Objectives:

• support innovative, high-quality, collaborative research that focuses on interventions to improve prevention, diagnosis and treatment of AMR and DR-TB
• promote effective translation of research into health policy and/or practice
• develop strategies that improve outcomes for individuals and communities in our region
• build collaboration between Australia and Pacific Island Countries
• transfer knowledge between Australia and Pacific Island Countries to build workforce capability
• increase knowledge and understanding of AMR and DR-TB
• leverage collaborations between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare).

National Critical Infrastructure Initiative

Grant objectives:

• improved facilities, equipment, services and systems in rural, regional and remote Australia
• improved quality of care and health outcomes for patients through quicker and easier access to medical treatments, drugs, therapies and devices, through participation in clinical trials
• reduced burden, costs and risks for patients and their families related to clinical trial participation
• increased research capacity, including linkages, leveraging and enhancements of existing local and national structures, organisations, facilities and/or workforce, with flow-on effects to broader health services

Emerging Priorities and Consumer Driven Research Initiative

Grant objectives:

• reduce barriers to clinical uptake of pharmacogenomics testing for patients presenting with neuropsychiatric conditions
• address gaps in evidence related to the application of pharmacogenomics for neuropsychiatric conditions
• encourage research that combines new or existing technologies with large-scale data, machine learning, clinical information, or patient biomarkers to develop new or refine existing tests that facilitate improved personalisation and efficacy of psychotropic medication regimens.

Primary Health Care Research Initiative

Priority primary health care research topics:

• the provision of primary health care services in residential aged care and to older Australians in the community
• lessons from comprehensive primary health care service for Indigenous Australians for the broader primary health care system
• mental health service provision by general practice
• application of precision medicine and genomics in primary health care
• rural and regional access to services
• workforce issues, including scope of practice
• voluntary patient enrolment and blended payments

Preventive and Public Health Research Initiative

Priority areas: 

• Maternal health and the first 2000 days
• Early childhood, and
• Exercise and nutrition. 

Preventive and Public Health Research Initiative

Grant objectives:

1. Cancer treatment population
2. Tools to value health change in paediatric populations
3. Efficient use of high cost pharmaceuticals
4. Digital breast tomosynthesis
5. Circumcision revision

Million Minds Mission

Grant objectives:

• support innovative, high quality, collaborative research that focuses on interventions to prevent suicide

• promote effective translation of research into health policy and/or practice

• foster and build workforce capacity and workforce capability

• leverage collaborations between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare)

Emerging Priorities and Consumer Driven Research (EPCDR)

Grant objectives: 

• facilitate innovative, high quality research that will lead to:
  • improved diagnosis and treatment of endometriosis
  • research that will address the gaps in research, leading to a better understanding of the causes and underlying factors that contribute to the development and progression of endometriosis
• facilitate consumer involvement in the design and evaluation of the research project (including participation in the conduct of the research) 
• provide high-quality evidence for new health treatments and/or drugs (where appropriate)
• enable rapid translation of consumer-relevant research into clinical practice, health policy, and/or health advice that will lead to positive impacts for consumers
• encourage the development of multi-disciplinary research teams that deliver measurable outcomes that are a priority for consumers
• encourage collaboration between research teams, policy makers, healthcare funders and the health delivery sector (e.g. education, community, industry and/or healthcare).

Indigenous Health Research Fund initiative

Grant Objectives:

• Indigenous-led research project
• Ending avoidable blindness
• Ending avoidable deafness
• Chronic kidney disease prevention
• Adolescent mental health

Rare Cancers, Rare Diseases and Unmet Need Clinical Trials initiative

Grant Objective: Clinical trial that addresses a gap in current research and/or knowledge in rare cancers, rare diseases and areas of unmet medical need.

Rare Cancers, Rare Diseases and Unmet Need Clinical Trials initiative

Grant Objective: Clinical trials that address a gap in current research and/or knowledge in neurological disorders, including (but not limited to) Duchenne Muscular Dystrophy (DMD), spinal cord injuries (SCI) and Autism Spectrum Disorders (ASD).

Emerging Priorities and Consumer-Driven Research initiative

Grant Objectives:

• reduce barriers to clinical uptake of pharmacogenomics testing for patients presenting with neuropsychiatric conditions
• address gaps in evidence related to the application of pharmacogenomics for neuropsychiatric conditions
• encourage research that combines new or existing technologies with large-scale data, machine learning, clinical information, or patient biomarkers to develop new or refine existing tests that facilitate improved personalisation and efficacy of psychotropic medication regimens.

Rare Cancers, Rare Diseases and Unmet Need Clinical Trials initiative

Grant Objective: Clinical trial that addresses a gap in current research and/or knowledge in childhood brain cancer.

Rare Cancers, Rare Diseases and Unmet Need Clinical Trials initiative

Grant Objective: Clinical trial that addresses a gap in current research and/or knowledge in reproductive cancer.